For its third fiscal quarter (ending September 30), Huntsman Corp (NYSE: HUN) has reported E.P.S. of $-0.12 compared to $0.00 a year ago. For the latest four quarters through September 30, E.P.S. were $-0.62 compared […]
Entegris Inc (NASDAQ: ENTG) has reported E.P.S. of $0.51 for its third fiscal quarter (ending September 30) versus $0.22 for the same period a year ago — an increase of 132%. For the latest four […]
On 11/4/24, Proto Labs Inc (NYSE: PRLB) stock suffered a major decline of -10.9%, closing at $33.86. Moreover, this decline was accompanied by exceptionally high trading volume at 297% of normal. The stock has been […]
Capital Southwest Corp (NASDAQ: CSWC) suffers from extremely meaningful negative changes in investment behavior: its longer term price trend turned down, its shorter term price trend turned down, the stock fell on very heavy volume, […]
TriMas Corp (NASDAQ: TRS) has reported E.P.S. of $0.06 for its third fiscal quarter (ending September 30) versus $0.40 for the same period a year ago — a decline of -85%. E.P.S. were $0.65 for […]
Teradata Corporation (NYSE: TDC) has reported E.P.S. of $0.33 for its third fiscal quarter (ending September 30) versus $0.12 for the same period a year ago — an increase of 175%. For the latest four […]
Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has reported E.P.S. of $0.70 for its third fiscal quarter (ending September 30) versus $-0.29 for the same period a year ago — a decline of -341%. For the latest […]
For its third fiscal quarter (ending September 30), Hudson Technologies Inc (NASDAQ: HDSN) has reported a -43% decline in E.P.S. from $0.30 a year ago to $0.17 in the current quarter. For the latest four […]
For its fourth fiscal quarter (ending September 30), Hologic Inc (NASDAQ: HOLX) has reported a 105% increase in E.P.S. from $0.37 a year ago to $0.76 in the current quarter. For the latest four quarters […]
Canopy Growth Corp (NASDAQ: CGC) stock enjoyed a major increase of 13.0% on 11/4/24. The shares closed at $5.49. Moreover, trading volume in this advance was exceptionally high at 329% of normal. The stock has […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research